Piramal Pharma Solutions to Collaborate with Epirium Bio
26 Aug 2020 //
PRNEWSWIRE
Epirium Bio Announces Commencement of Phase 1 Clinical Trial of EPM-01
12 Aug 2020 //
BUSINESSWIRE
Epirium Bio Receives FDA Orphan-Drug Designation for EB 002 ((+)-Epicatechin)
14 Apr 2020 //
BUSINESSWIRE
Epirium Raises $85 Million in Series A Financing
18 Dec 2019 //
BUSINESS WIRE